Polymorphonuclear myeloid-derived suppressor cells protect against hyperoxia-induced bronchopulmonary dysplasia in neonatal mice through suppression of excessive inflammatory response
- 14 June 2025
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 414, 104995
Abstract
No abstract availableKeywords
Funding Information
- Shenzhen Science and Technology Innovation Program
- Shenzhen Science and Technology Innovation Committee (JCYJ20220530152415034, JCYJ20230807112405011, JCYJ20240813103910014)
This publication has 38 references indexed in Scilit:
- PMN-MDSC in newborns: Regulation of the regulatorsJournal of Leukocyte Biology, 2022
- Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018JAMA, 2022
- Analysis of Factors Associated With Body Mass Index at Ages 18 and 36 Months Among Infants Born Extremely PretermJAMA Network Open, 2021
- Changes in Use of Respiratory Support for Preterm Infants in the US, 2008-2018JAMA Pediatrics, 2021
- Lung growth and pulmonary function after prematurity and bronchopulmonary dysplasiaPediatric Pulmonology, 2021
- Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)Stem Cells Translational Medicine, 2021
- Preterm birth and sustained inflammation: consequences for the neonateSeminars in Immunopathology, 2020
- Lung development and emerging roles for type 2 immunityThe Journal of Pathology, 2018
- Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm InfantsJAMA Pediatrics, 2017
- Hospital Variation and Risk Factors for Bronchopulmonary Dysplasia in a Population-Based CohortJAMA Pediatrics, 2015